Trials / Completed
CompletedNCT02580578
A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids
A Multicentre Prospective Non-interventional Study Assessing the Management of Canadian Women With Uterine Fibroids, a Patient Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (actual)
- Sponsor
- Allergan · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will characterize the treatments and outcomes associated with different uterine fibroid treatments in Canada, to understand patients' preferences and satisfaction with different medical and procedural interventions. The study will also assess the effectiveness of ulipristal acetate (Fibristal®) in controlling bleeding, reducing fibroid volume and symptoms, and improvement in patient's quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No intervention is administered in this study. |
Timeline
- Start date
- 2015-07-31
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
- First posted
- 2015-10-20
- Last updated
- 2020-02-28
Locations
20 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02580578. Inclusion in this directory is not an endorsement.